Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 2965: Generation of a human breast tissue mimetic organoid model

Tian-Yu Lee, Nadya Nikulina, Srivarshini C. Mohan, Edward Ray, Armando Giuliano, Oliver Braubach, Xiaojiang Cui

Cancer Res (2021) 81 (13_Supplement): 2965.

https://doi.org/10.1158/1538-7445.AM2021-2965

Published: 01 July 2021

View article titled, Abstract 2965: Generation of a human breast tissue mimetic organoid model

Journal Articles

Abstract 726: Constitutive NF-kB-activation loop enhances resistance to trastuzumab in HER2 positive luminal B breast cancer

Hirotaka Kanzaki, Nishit Makhopadhya, Xiaojiang Cui, Krishnan V. Ramanujan, Tatsuaki Takeda, Yoshihisa Kitamura, Toshiaki Sendo, Ramachandran Murali

Cancer Res (2015) 75 (15_Supplement): 726.

https://doi.org/10.1158/1538-7445.AM2015-726

Published: 01 August 2015

View article titled, Abstract 726: Constitutive NF-kB-activation loop enhances resistance to trastuzumab in HER2 positive luminal B breast cancer

Journal Articles

Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer

Bingchen Han, Yanli Jin, Shikha Bose, Xiao Zhang, Ying Qu, Beth Y. Karlan, Armando E. Giuliano, Xiaojiang Cui

Cancer Res (2014) 74 (19_Supplement): 1906.

https://doi.org/10.1158/1538-7445.AM2014-1906

Published: 01 October 2014

View article titled, Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer

Journal Articles

Abstract 4487: Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

Jessica Sims, Michael Taguaim, Chris Hanson, Xiaojiang Cui, Lali K. Medina-Kauwe

Cancer Res (2014) 74 (19_Supplement): 4487.

https://doi.org/10.1158/1538-7445.AM2014-4487

Published: 01 October 2014

View article titled, Abstract 4487: Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

Journal Articles

Abstract A101: Treating trastuzumab-resistant HER2+ breast cancers with a HER3-targeted nanoparticle

Jessica D. Sims, Michael Taguaim, Chris Hanson, Xiaojiang Cui, Lali K. Medina-Kauwe

Cancer Res (2013) 73 (3_Supplement): A101.

https://doi.org/10.1158/1538-7445.TIM2013-A101

Published: 01 May 2014

View article titled, Abstract A101: Treating trastuzumab-resistant HER2+ breast cancers with a HER3-targeted nanoparticle

Journal Articles

Abstract 5443: FOXC1 is a critical mediator of EGFR function in basal-like breast cancer.

Yanli Jin, Bingchen Han, Wolf Ruprecht Wiedemeyer, Sandra Orsulic, Beth Karlan, Armando Giuliano, Xiaojiang Cui

Cancer Res (2013) 73 (8_Supplement): 5443.

https://doi.org/10.1158/1538-7445.AM2013-5443

Published: 15 April 2013

View article titled, Abstract 5443: FOXC1 is a critical mediator of EGFR function in basal-like breast cancer.

Journal Articles

Abstract 1511: Stromal gene signature regulated by TGFβ signaling predicts poor clinical outcome in ovarian cancer .

Dong-Joo Cheon, Yunguang Tong, Myung-Shin Sim, Xiaojiang Cui, Dror Berel, Mourad Tighiouart, Wolf Ruprecht Wiedemeyer, Beth Karlan, Sandra Orsulic

Cancer Res (2013) 73 (8_Supplement): 1511.

https://doi.org/10.1158/1538-7445.AM2013-1511

Published: 15 April 2013

View article titled, Abstract 1511: Stromal gene signature regulated by TGFβ signaling predicts poor clinical outcome in ovarian cancer .

Journal Articles

Abstract 3138: FOXC1 represses estrogen receptor-α expression via increasing NF-κB activity in breast cancer: A novel mechanism to explain antiestrogen resistance

Jinhua Wang, Guifa Li, Partha Ray, Myung-Shin Sim, Michael A. Walter, Armando E. Giuliano, Xiaojiang Cui

Cancer Res (2011) 71 (8_Supplement): 3138.

https://doi.org/10.1158/1538-7445.AM2011-3138

Published: 15 April 2011

View article titled, Abstract 3138: FOXC1 represses estrogen receptor-α expression via increasing NF-κB activity in breast cancer: A novel mechanism to explain antiestrogen resistance

Journal Articles

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

Partha S. Ray, Jinhua Wang, Ying Qu, Myung-Shin Sim, Jaime Shamonki, Sanjay P. Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S. Hoon, Michael A. Walter, John W. Martens, Andrea L. Richardson, Armando E. Giuliano, Xiaojiang Cui

Cancer Res (2010) 70 (10): 3870–3876.

https://doi.org/10.1158/0008-5472.CAN-09-4120

Published: 12 May 2010

View article titled, FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract 1794: TXNL2 is a key regulator of reactive oxygen species levels and NF-κB activity in cancer cells

Ying Qu, Jinhua Wang, Miyung Shin-Sim, Jiang Huang, Bingya Liu, Ning Zhang, Yukung Cui, Armando E. Giuliano, Ninghui Cheng, Xiaojiang Cui

Cancer Res (2010) 70 (8_Supplement): 1794.

https://doi.org/10.1158/1538-7445.AM10-1794

Published: 15 April 2010

View article titled, Abstract 1794: TXNL2 is a key regulator of reactive oxygen species levels and NF-κB activity in cancer cells

Journal Articles

Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer

Jinhua Wang, Partha Ray, Ying Qu, Myung-Shin Sim, Jaime Shamonki, Sanjay Bagaria, Xing Ye, Bingya Liu, Michael Walter, Dave Hoon, Armando Giuliano, Xiaojiang Cui

Cancer Res (2010) 70 (8_Supplement): 3742.

https://doi.org/10.1158/1538-7445.AM10-3742

Published: 15 April 2010

View article titled, Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer

Journal Articles

Abstract #4579: Elesclomol and chemotherapy agents synergistically induce apoptosis in breast cancer cells

Ying Qu, Jinhua Wang, Bingya Liu, Armando Giuliano, James Barsoum, Xiaojiang Cui

Cancer Res (2009) 69 (9_Supplement): 4579.

Published: 01 May 2009

View article titled, Abstract #4579: Elesclomol and chemotherapy agents synergistically induce apoptosis in breast cancer cells

Journal Articles

Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH₂-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration

Xiaojiang Cui, Hyun-Jung Kim, Isere Kuiatse, Heetae Kim, Powel H. Brown, Adrian V. Lee

Cancer Res (2006) 66 (10): 5304–5313.

https://doi.org/10.1158/0008-5472.CAN-05-2858

Published: 16 May 2006

View article titled, Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH<sub>2</sub>-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration

Journal Articles

Glucocorticoids sensitize MCF-10A human mammary epithelial cells to IGF-I in part via upregualtion of insulin receptor substrate-1 (IRS-1)

Hyun-Jung Kim, Xiaojiang Cui, Adrian V. Lee

Cancer Res (2005) 65 (9_Supplement): 866.

Published: 01 May 2005

View article titled, Glucocorticoids sensitize MCF-10A human mammary epithelial cells to IGF-I in part via upregualtion of insulin receptor substrate-1 (IRS-1)

Journal Articles

Estrogen-mediated Down-Regulation of E-cadherin in Breast Cancer Cells

Steffi Oesterreich, Wanleng Deng, Shiming Jiang, Xiaojiang Cui, Margarita Ivanova, Rachel Schiff, Kaiyan Kang, Darryl L. Hadsell, Jürgen Behrens, Adrian V. Lee

Cancer Res (2003) 63 (17): 5203–5208.

Published: 18 September 2003

View article titled, Estrogen-mediated Down-Regulation of E-cadherin in Breast Cancer Cells

NARROW

Abstract 2965: Generation of a human breast tissue mimetic organoid model

Abstract 726: Constitutive NF-kB-activation loop enhances resistance to trastuzumab in HER2 positive luminal B breast cancer

Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer

Abstract 4487: Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

Abstract A101: Treating trastuzumab-resistant HER2+ breast cancers with a HER3-targeted nanoparticle

Abstract 5443: FOXC1 is a critical mediator of EGFR function in basal-like breast cancer.

Abstract 1511: Stromal gene signature regulated by TGFβ signaling predicts poor clinical outcome in ovarian cancer .

Abstract 3138: FOXC1 represses estrogen receptor-α expression via increasing NF-κB activity in breast cancer: A novel mechanism to explain antiestrogen resistance

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

Abstract 1794: TXNL2 is a key regulator of reactive oxygen species levels and NF-κB activity in cancer cells

Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer

Abstract #4579: Elesclomol and chemotherapy agents synergistically induce apoptosis in breast cancer cells

Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH₂-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration

Glucocorticoids sensitize MCF-10A human mammary epithelial cells to IGF-I in part via upregualtion of insulin receptor substrate-1 (IRS-1)

Estrogen-mediated Down-Regulation of E-cadherin in Breast Cancer Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only